Phase 2 trial – Page 2

Merck’s Investigational ADC Zilovertamab Vedotin Enters Phase 3 with 100% Complete Response Rate in DLBCL Patients

5 months ago talkbio0Tagged Antibody-Drug Conjugates, Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Phase 2 trial, Phase 3 trial, Programs - Publication Format, ROR1 protein, human, vedotin, Zilovertamab

Zilovertamab Vedotin, Antibody-Drug Conjugate (ADC), Diffuse Large B-Cell Lymphoma (DLBCL), Phase 2 Trial, Phase 3 Trial, ROR1, Merck, waveLINE Program

BioAge Labs Halts Phase 2 Obesity Trial Due to Liver Safety Concerns Just Two Months After IPO

5 months ago talkbio0Tagged Azelaprag, BioAge Labs, concerns, Eli, Eli Lilly, IPO, liver safety, Obesity, Phase 2 trial

BioAge Labs, Phase 2 trial, obesity, liver safety concerns, azelaprag, Eli Lilly, tirzepatide, IPO

Protara Therapeutics Sees Significant Stock Surge Following Positive Phase 2 Trial Results for TARA-002 in Bladder Cancer

5 months ago talkbio0Tagged Lyophilized Inactivated Group A Streptococcus TARA-002, Malignant neoplasm of urinary bladder, Non-Muscle Invasive Bladder Neoplasms, Phase 2 trial, Protara Therapeutics, safety profile

Protara Therapeutics, TARA-002, bladder cancer, NMIBC, Phase 2 trial, complete response rate, safety profile

PTC Therapeutics Sells Priority Review Voucher for $150M Following Phase 2 ALS Trial Failure

5 months ago talkbio0Tagged Amyotrophic Lateral Sclerosis, factor IX, Failure (biologic function), Phase 2 trial, Priority Review

PTC Therapeutics, ALS, Phase 2 trial failure, priority review voucher, $150M sale

PTC Therapeutics Discontinues Utreloxastat Program Following Phase 2 ALS Trial Failure

5 months ago talkbio0Tagged Amyotrophic Lateral Sclerosis, Cardinalis cardinalis, factor IX, Phase 2 trial, Utreloxastat

PTC Therapeutics, Utreloxastat, ALS, Phase 2 Trial, CardinALS Study, Amyotrophic Lateral Sclerosis

Alector Cuts 17% of Workforce Following Failure of AbbVie-Partnered Alzheimer’s Drug in Phase 2 Trial

5 months ago talkbio0Tagged AbbVie, Alector, Alzheimer 's disease, Failure (biologic function), Industry, Phase 2 trial

Alector, layoffs, AbbVie, Alzheimer’s disease, phase 2 trial failure, biotech industry

ESSA Pharma Terminates Masofaniten Development After Phase 2 Trial Failure in Prostate Cancer

6 months ago talkbio0Tagged Clinical Trial Termination, enzalutamide, ESSA, Malignant neoplasm of prostate, masofaniten, Pharma, Phase 2 trial

ESSA Pharma, Masofaniten, Prostate Cancer, Phase 2 Trial, Enzalutamide, Xtandi, Clinical Trial Termination

MeiraGTx’s Gene Therapy Shows Significant Improvements in Motor Function and Quality of Life in Parkinson’s Disease Trial

6 months ago talkbio0Tagged AAV-GAD, Clinical Trials, dopamine, gamma-aminobutyric acid, gene therapy, MeiraGTx, Motor function (observable entity), Neurodegenerative Disorders, Parkinson 's disease, Phase 2 trial, production, Quality of life, Surgical Replantation

MeiraGTx, Gene Therapy, Parkinson’s Disease, AAV-GAD, Motor Function, Quality of Life, Clinical Trial, Phase 2 Trial, Neurodegenerative Disease, Dopamine Replacement, GABA Production